Access to premium content is restricted to healthcare professionals / registered members. Login with your email address to continue.
Forgot Your Password?
Follow Topic
Bookmark
New test from PocDoc promises results “in minutes”.
21 Aug 2025
For those with type 2 diabetes and no significant comorbidity, or with heart failure, SGLT-2 inhibitors now a first choice treatment alongside metformin.
20 Aug 2025
... but teplizumab yet to receive the thumbs-up from NICE.
19 Aug 2025
Study warns delays in cancer biomarker testing are hindering access to NICE-approved targeted therapies.
15 Aug 2025
Health experts said early testing for testosterone deficiency in men with and without type 2 diabetes will "reduce the health and cost impact" of the condition.
08 Aug 2025
Healthcare providers will be expected to monitor people for at least a year after they come off obesity medication, according to new guidance.
05 Aug 2025
Prioritise active TB cases to conserve supplies, MHRA tells prescribers
31 Jul 2025
Patients require positive skin prick or blood tests confirming allergy before accessing the therapy.
22 Jul 2025
EURneffy (adrenaline 2mg): ready-to-use, needle-free intranasal spray for emergency treatment of anaphylaxis.
21 Jul 2025
Pfizer is reintroducing its Champix prescription only smoking cessation medicine into the UK after withdrawing it over safety concerns in 2021.
01 Jul 2025
Patients with diabetes who start statins promptly reduce chances of MI and ischemic stroke by one third, researchers say.
09 Jun 2025
Antibiotic-treated children were 20 per cent more likely than controls to be obese at 12 years of age.
22 May 2025
Guselkumab already approved for plaque psoriasis and psoriatic arthritis, but studies show it is also effective in moderate to severe Crohn’s disease and UC.
20 May 2025
Rowlands Pharmacy's collaboration with TympaHealth will see its branches conduct ear examinations via video using the latter's digital platform.
08 May 2025
Public swapping unused antibiotics on Facebook, finds new NPA survey
06 May 2025
Analysing data from 2016 to 2020, researchers found 6.3 per cent of bacteria showed resistance to ceftazidime/avibactam.
29 Apr 2025
